Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP699415.RAfX70ALSvPRG5WSNu-1_aGzHyx7ILgVQDNkj_5vXa2YY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP699415.RAfX70ALSvPRG5WSNu-1_aGzHyx7ILgVQDNkj_5vXa2YY130_assertion type Assertion NP699415.RAfX70ALSvPRG5WSNu-1_aGzHyx7ILgVQDNkj_5vXa2YY130_head.
- NP699415.RAfX70ALSvPRG5WSNu-1_aGzHyx7ILgVQDNkj_5vXa2YY130_assertion wasGeneratedBy ECO_0000203 NP699415.RAfX70ALSvPRG5WSNu-1_aGzHyx7ILgVQDNkj_5vXa2YY130_provenance.
- NP699415.RAfX70ALSvPRG5WSNu-1_aGzHyx7ILgVQDNkj_5vXa2YY130_assertion wasDerivedFrom befree-20140225 NP699415.RAfX70ALSvPRG5WSNu-1_aGzHyx7ILgVQDNkj_5vXa2YY130_provenance.
- NP699415.RAfX70ALSvPRG5WSNu-1_aGzHyx7ILgVQDNkj_5vXa2YY130_assertion SIO_000772 21393427 NP699415.RAfX70ALSvPRG5WSNu-1_aGzHyx7ILgVQDNkj_5vXa2YY130_provenance.
- NP699415.RAfX70ALSvPRG5WSNu-1_aGzHyx7ILgVQDNkj_5vXa2YY130_assertion evidence source_evidence_literature NP699415.RAfX70ALSvPRG5WSNu-1_aGzHyx7ILgVQDNkj_5vXa2YY130_provenance.
- NP699415.RAfX70ALSvPRG5WSNu-1_aGzHyx7ILgVQDNkj_5vXa2YY130_assertion description "[Treatment of SK-BR-3 breast cancer xenografts with anti-HER2 IgG3-huEndo-P125A fusion resulted in greater inhibition of tumor growth and improved survival, compared to treatment with either αHER2 IgG3 (P = 0.025), human endostatin (P = 0.034), or anti-HER2 IgG3-huEndo (P = 0.016).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699415.RAfX70ALSvPRG5WSNu-1_aGzHyx7ILgVQDNkj_5vXa2YY130_provenance.